Cosmic Crypto ClubCosmic Crypto Club
Home
Markets
Tools
Academy
Brokers
DiscordLaunch Hub
Cosmic Crypto Club

Free trading education, market data & a community of serious traders. Join thousands learning to trade Crypto, Forex & Stocks.

Markets

  • Market Overview
  • Cryptocurrencies
  • Stocks
  • Forex
  • Indices
  • Commodities
  • News

Tools & Software

  • All Tools
  • Calculators
  • Screener
  • Economic Calendar
  • Trading Journal
  • Trading Software

Academy

  • Academy Home
  • Strategies
  • Glossary
  • How-To Guides
  • DeFi Protocols
  • Tax Guides

Brokers & Company

  • All Brokers
  • Crypto Exchanges
  • Prop Firms
  • About Us
  • Contact
  • FAQ

© 2026 Cosmic Crypto Club. All rights reserved.

Terms of ServicePrivacy PolicyCookie PolicyAffiliate DisclosureRisk & Investment Disclaimer

The information on cosmiccrypto.club is provided for general information purposes only. It does not constitute legal, financial, or professional advice. Cosmiccrypto.club does not accept responsibility for any loss or damage arising from reliance on the site's content. Users should seek independent advice and information before making financial decisions. Trading cryptocurrencies, stocks, and other financial instruments involves substantial risk and may not be suitable for every investor.

Back to Stocks
DNLI
Rank #1891DNLI

Denali Therapeutics Inc.

$20.24

5.25% (Daily)

Market Cap

$3.16B

Revenue

$N/A

Rank by MCap

#1891

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Ryan J. Watts Ph.D.

Headquarters

South San Francisco, CA

Employees

517

About Denali Therapeutics Inc.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; DNL343 eIF2B activator program for amyotrophic lateral sclerosis; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo S...

Denali Therapeutics Inc. Price Chart

Loading chart…

Community & Socials

Website

Explore Related

Browse ETFsExplore CryptocurrencyView All S&P 500 Stocks